.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Enalapril maleate; hydrochlorothiazide - Generic Drug Details

« Back to Dashboard
Enalapril maleate; hydrochlorothiazide is the generic ingredient in two branded drugs marketed by Dr Reddys Labs Ltd, Upsher-smith Labs, Valeant Intl, Mylan, G And W Labs Inc, Ivax Sub Teva Pharms, Apotex Inc, and Taro Pharm Inds, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-seven drug master file entries for enalapril maleate; hydrochlorothiazide. Twelve suppliers are listed for this compound.

Summary for Generic Name: enalapril maleate; hydrochlorothiazide

Tradenames:2
Patents:0
Applicants:8
NDAs:8
Drug Master File Entries: see list27
Suppliers / Packaging: see list12
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: enalapril maleate; hydrochlorothiazide

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro Pharm Inds
ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE
enalapril maleate; hydrochlorothiazide
TABLET;ORAL075788-001Sep 18, 2001RXNo► subscribe► subscribe
Mylan
ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE
enalapril maleate; hydrochlorothiazide
TABLET;ORAL075624-002Sep 18, 2001RXNo► subscribe► subscribe
Mylan
ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE
enalapril maleate; hydrochlorothiazide
TABLET;ORAL075624-001Sep 18, 2001RXNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: enalapril maleate; hydrochlorothiazide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Intl
VASERETIC
enalapril maleate; hydrochlorothiazide
TABLET;ORAL019221-003Jul 12, 19954,374,829*PED► subscribe
Valeant Intl
VASERETIC
enalapril maleate; hydrochlorothiazide
TABLET;ORAL019221-001Oct 31, 19864,374,829*PED► subscribe
Valeant Intl
VASERETIC
enalapril maleate; hydrochlorothiazide
TABLET;ORAL019221-001Oct 31, 19864,472,380*PED► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc